Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in patients with Type 2 Diabetes Mellitus.
about
Treatment of patients with type 2 diabetes and non-alcoholic fatty liver disease: current approaches and future directionsPractical strategies for improving outcomes in T2DM: The potential role of pioglitazone and DPP4 inhibitors.Comparison of Pioglitazone and Metformin Efficacy against Glucocorticoid Induced Atherosclerosis and Hepatic Steatosis in Insulin Resistant Rats.Inhibition of exendin-4-induced steatosis by protein kinase A in cultured HepG2 human hepatoma cells.Response to: Drug therapy for ectopic fat: myth or reality?
P2860
Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in patients with Type 2 Diabetes Mellitus.
description
2016 nî lūn-bûn
@nan
2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Treatment of Nonalcoholic Fatt ...... with Type 2 Diabetes Mellitus.
@ast
Treatment of Nonalcoholic Fatt ...... with Type 2 Diabetes Mellitus.
@en
type
label
Treatment of Nonalcoholic Fatt ...... with Type 2 Diabetes Mellitus.
@ast
Treatment of Nonalcoholic Fatt ...... with Type 2 Diabetes Mellitus.
@en
prefLabel
Treatment of Nonalcoholic Fatt ...... with Type 2 Diabetes Mellitus.
@ast
Treatment of Nonalcoholic Fatt ...... with Type 2 Diabetes Mellitus.
@en
P2860
P1476
Treatment of Nonalcoholic Fatt ...... with Type 2 Diabetes Mellitus.
@en
P2093
Kenneth Cusi
Paola Portillo-Sanchez
P2860
P2888
P356
10.1186/S40842-016-0027-7
P577
2016-04-12T00:00:00Z
P5875
P6179
1023957078